Centre rejects RTI seeking details on COVID-19 vaccine pricing, says ‘prejudicially affect interests of State’
| |

Centre rejects RTI seeking details on COVID-19 vaccine pricing, says ‘prejudicially affect interests of State’

BySaurav Das

The article was originally published in Firstpost. Read here. Most experts agree that Centre has fixed current price of COVID-19 vaccine at Rs 250 only after factoring in the reduced expenses of the two companies, large volume of orders they are to get, affordability of the masses and the major hurdle of vaccine hesitancy it faces….

As India preps for COVID-19 vaccine rollout, Centre says ‘no proposal’ to indemnify vaccine manufacturers
| |

As India preps for COVID-19 vaccine rollout, Centre says ‘no proposal’ to indemnify vaccine manufacturers

BySaurav Das

The article was originally published in Firstpost. Read here. Centre in response to an RTI filed said that it currently has no proposal to indemnify or exempt vaccine manufacturers from any liability in case of serious side-effects/adverse reactions due to inoculation of their vaccines. On 3 January, the Government of India gave its final approval for…